Wantstats
Company ProfilePremium

Danaher

Company Profile Analysis

Book DemoRegister Your Interest
ESOMAR 23 Corporate BadgeISO Certifications Badge
Danaher - Healthcare showcase

Year Founded & Workforce

1969

71,000 Employees

Industry

Healthcare

Services

Clear AlignersOrmcoImmunoassay Analyzers (Beckman Coulter)Immunoassay Testing (RADIOMETER)
D

Danaher Employee Contacts

196 verified contactsNames, job titles, seniority and locations

View Employee Contacts

Danaher Overview

Company Headquarters: Washington, D.C., US

Founded: 1969

Workforce: ~71,000

Company Working: Danaher designs, manufactures, and markets professional, medical, industrial, and commercial products and services all over the world. The company has five business segments, namely, life sciences, diagnostics, dental, water quality, and product identification. Its life sciences segment provides laser scanning, compound, surgical, and other stereo microscopes. It also offers dental implant systems, high-precision individualized prosthetics, and CAD/CAM systems under the brand name Nobel Biocare. The company operates through more than 20 subsidiaries in the global market.

Strategy

Danaher is actively entering into joint ventures and acquisitions. Additionally, the company aims to enhance its science and technology product portfolio through strategic capital allocations. Danaher recently opened a new Danaher Innovation Center in Cambridge, Massachusetts, US to enhance its product portfolio in its life sciences segment.

Company Snapshot

$16,882.4M

Revenue

71,000

Employees

1969

Founded

Washington, D.C., US

Headquarters

SWOT Analysis

Strengths

  • Industrial diversity and unique products
  • High customer loyalty
  • Strong management and high expertise
  • Worldwide presence
  • Diverse business segments
  • Strong brand value

Weaknesses

  • High indebtedness
  • Relatively less market penetration outside the US market
  • Product recalls in the recent years can negatively affect the company’s image

Opportunities

  • Acquisitions to strengthen industrial technologies and the diagnostic business
  • Product and service expansion
  • Strategic mergers
  • Increasing demand for immunoassay products
  • Product launches

Threats

  • Intense competition in the market
  • Changes in regulations of healthcare and related industries
  • Pricing pressure from established regional & global market plyers
  • Fluctuating exchange rates

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateApproachDevelopment
July 2018ExpansionDanaher announced its intention to spin off its dental segment into an independent, publicly-traded company ("DentalCo"). The transaction is intended to be tax-free to Danaher shareholders and expected to be completed by the second half of 2019. DentalCo will be a premier global partner for the dental community, with industry-leading positions and brands providing world-class innovation, service, and solutions for customers.

Product Offering

  • Danaher
    • Clear Aligners
    • Ormco
    • Immunoassay Analyzers (Beckman Coulter)
    • Immunoassay Testing (RADIOMETER)

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

By Business Segment: Total Revenue rose from USD 16,882.4 Mn in 2016 to USD 19,893 Mn in 2018.
Danaher — By Business Segment
Series (USD Mn)201620172018
Total Revenue16,882.418,329.719,893

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.

Get Contacts →